Bharat Biotech’s Typbar-TCV vaccine confirms high efficacy in TCV human challenge study
According to the trial’s results published in The Lancet, the vaccine turned out to be 87 per cent effective for infants, older…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.